ID   S52A2_HUMAN             Reviewed;         445 AA.
AC   Q9HAB3; A8K6B6; D3DWL8; G1UCY1; Q86UT1;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 121.
DE   RecName: Full=Solute carrier family 52, riboflavin transporter, member 2;
DE   AltName: Full=Porcine endogenous retrovirus A receptor 1;
DE            Short=PERV-A receptor 1;
DE   AltName: Full=Protein GPR172A;
DE   AltName: Full=Riboflavin transporter 3;
DE            Short=hRFT3;
GN   Name=SLC52A2; Synonyms=GPR172A, PAR1, RFT3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND FUNCTION AS A
RP   VIRAL RECEPTOR.
RX   PubMed=12740431; DOI=10.1073/pnas.1138025100;
RA   Ericsson T.A., Takeuchi Y., Templin C., Quinn G., Farhadian S.F.,
RA   Wood J.C., Oldmixon B.A., Suling K.M., Ishii J.K., Kitagawa Y.,
RA   Miyazawa T., Salomon D.R., Weiss R.A., Patience C.;
RT   "Identification of receptors for pig endogenous retrovirus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:6759-6764(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20463145; DOI=10.3945/jn.110.122911;
RA   Yao Y., Yonezawa A., Yoshimatsu H., Masuda S., Katsura T., Inui K.;
RT   "Identification and comparative functional characterization of a new
RT   human riboflavin transporter hRFT3 expressed in the brain.";
RL   J. Nutr. 140:1220-1226(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION AS A VIRAL RECEPTOR.
RX   PubMed=19307586; DOI=10.1073/pnas.0809741106;
RA   Mazari P.M., Linder-Basso D., Sarangi A., Chang Y., Roth M.J.;
RT   "Single-round selection yields a unique retroviral envelope utilizing
RT   GPR172A as its host receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:5848-5853(2009).
RN   [8]
RP   VARIANT BVVLS2 ARG-306.
RX   PubMed=22740598; DOI=10.1093/brain/aws161;
RA   Johnson J.O., Gibbs J.R., Megarbane A., Urtizberea J.A.,
RA   Hernandez D.G., Foley A.R., Arepalli S., Pandraud A.,
RA   Simon-Sanchez J., Clayton P., Reilly M.M., Muntoni F., Abramzon Y.,
RA   Houlden H., Singleton A.B.;
RT   "Exome sequencing reveals riboflavin transporter mutations as a cause
RT   of motor neuron disease.";
RL   Brain 135:2875-2882(2012).
RN   [9]
RP   VARIANTS BVVLS2 PRO-123 AND PRO-339, CHARACTERIZATION OF VARIANTS
RP   BVVLS2 PRO-123 AND PRO-339, AND FUNCTION.
RX   PubMed=22864630; DOI=10.1007/s10545-012-9513-y;
RA   Haack T.B., Makowski C., Yao Y., Graf E., Hempel M., Wieland T.,
RA   Tauer U., Ahting U., Mayr J.A., Freisinger P., Yoshimatsu H., Inui K.,
RA   Strom T.M., Meitinger T., Yonezawa A., Prokisch H.;
RT   "Impaired riboflavin transport due to missense mutations in SLC52A2
RT   causes Brown-Vialetto-Van Laere syndrome.";
RL   J. Inherit. Metab. Dis. 35:943-948(2012).
RN   [10]
RP   VARIANTS BVVLS2 PHE-52 AND SER-419, CHARACTERIZATION OF VARIANTS
RP   BVVLS2 PHE-52 AND SER-419, AND FUNCTION.
RX   PubMed=23243084; DOI=10.1136/jmedgenet-2012-101204;
RA   Ciccolella M., Corti S., Catteruccia M., Petrini S., Tozzi G.,
RA   Rizza T., Carrozzo R., Nizzardo M., Bordoni A., Ronchi D., D'Amico A.,
RA   Rizzo C., Comi G.P., Bertini E.;
RT   "Riboflavin transporter 3 involvement in infantile Brown-Vialetto-Van
RT   Laere disease: two novel mutations.";
RL   J. Med. Genet. 50:104-107(2013).
RN   [11]
RP   VARIANTS BVVLS2 SER-31; ASP-284; CYS-305; ARG-306; PRO-312 AND
RP   PRO-339, CHARACTERIZATION OF VARIANTS BVVLS2 SER-31; ASP-284; CYS-305;
RP   ARG-306; PRO-312 AND PRO-339, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24253200; DOI=10.1093/brain/awt315;
RA   Foley A.R., Menezes M.P., Pandraud A., Gonzalez M.A., Al-Odaib A.,
RA   Abrams A.J., Sugano K., Yonezawa A., Manzur A.Y., Burns J., Hughes I.,
RA   McCullagh B.G., Jungbluth H., Lim M.J., Lin J.P., Megarbane A.,
RA   Urtizberea J.A., Shah A.H., Antony J., Webster R., Broomfield A.,
RA   Ng J., Mathew A.A., O'Byrne J.J., Forman E., Scoto M., Prasad M.,
RA   O'Brien K., Olpin S., Oppenheim M., Hargreaves I., Land J.M.,
RA   Wang M.X., Carpenter K., Horvath R., Straub V., Lek M., Gold W.,
RA   Farrell M.O., Brandner S., Phadke R., Matsubara K., McGarvey M.L.,
RA   Scherer S.S., Baxter P.S., King M.D., Clayton P., Rahman S.,
RA   Reilly M.M., Ouvrier R.A., Christodoulou J., Zuechner S., Muntoni F.,
RA   Houlden H.;
RT   "Treatable childhood neuronopathy caused by mutations in riboflavin
RT   transporter RFVT2.";
RL   Brain 137:44-56(2014).
RN   [12]
RP   VARIANT BVVLS2 THR-141, CHARACTERIZATION OF VARIANT BVVLS2 THR-141,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=27702554; DOI=10.1016/j.cca.2016.09.022;
RA   Udhayabanu T., Subramanian V.S., Teafatiller T., Gowda V.K.,
RA   Raghavan V.S., Varalakshmi P., Said H.M., Ashokkumar B.;
RT   "SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van
RT   Laere syndrome in an Indian patient: First genetically proven case
RT   with mutations in two riboflavin transporters.";
RL   Clin. Chim. Acta 462:210-214(2016).
CC   -!- FUNCTION: Riboflavin transporter. Riboflavin transport is Na(+)-
CC       independent but moderately pH-sensitive. Activity is strongly
CC       inhibited by riboflavin analogs, such as lumiflavin. Weakly
CC       inhibited by flavin adenine dinucleotide (FAD) and flavin
CC       mononucleotide (FMN). In case of infection by retroviruses, acts
CC       as a cell receptor to retroviral envelopes similar to the porcine
CC       endogenous retrovirus (PERV-A). {ECO:0000269|PubMed:12740431,
CC       ECO:0000269|PubMed:19307586, ECO:0000269|PubMed:20463145,
CC       ECO:0000269|PubMed:22864630, ECO:0000269|PubMed:23243084,
CC       ECO:0000269|PubMed:24253200, ECO:0000269|PubMed:27702554}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.33 uM for riboflavin {ECO:0000269|PubMed:20463145};
CC   -!- INTERACTION:
CC       Q9UJX2:CDC23; NbExp=3; IntAct=EBI-10309896, EBI-396137;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20463145,
CC       ECO:0000269|PubMed:24253200, ECO:0000269|PubMed:27702554}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:20463145}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, fetal brain and
CC       salivary gland. Weakly expressed in other tissues.
CC       {ECO:0000269|PubMed:12740431, ECO:0000269|PubMed:20463145}.
CC   -!- DISEASE: Brown-Vialetto-Van Laere syndrome 2 (BVVLS2)
CC       [MIM:614707]: An autosomal recessive progressive neurologic
CC       disorder characterized by early childhood onset of sensorineural
CC       deafness, bulbar dysfunction, and severe diffuse muscle weakness
CC       and wasting resulting in respiratory insufficiency and loss of
CC       independent ambulation. Because it results from a defect in
CC       riboflavin metabolism, some patients may benefit from high-dose
CC       riboflavin supplementation. {ECO:0000269|PubMed:22740598,
CC       ECO:0000269|PubMed:22864630, ECO:0000269|PubMed:23243084,
CC       ECO:0000269|PubMed:24253200, ECO:0000269|PubMed:27702554}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the riboflavin transporter family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY070774; AAL59882.1; -; mRNA.
DR   EMBL; AB522904; BAK79010.1; -; mRNA.
DR   EMBL; AK021918; BAB13936.1; -; mRNA.
DR   EMBL; AK027888; BAB55433.1; -; mRNA.
DR   EMBL; AK291581; BAF84270.1; -; mRNA.
DR   EMBL; AF205589; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471162; EAW82115.1; -; Genomic_DNA.
DR   EMBL; CH471162; EAW82116.1; -; Genomic_DNA.
DR   EMBL; BC002917; AAH02917.1; -; mRNA.
DR   CCDS; CCDS6423.1; -.
DR   RefSeq; NP_001240744.1; NM_001253815.1.
DR   RefSeq; NP_001240745.1; NM_001253816.1.
DR   RefSeq; NP_078807.1; NM_024531.4.
DR   RefSeq; XP_006716721.1; XM_006716658.2.
DR   RefSeq; XP_006716722.1; XM_006716659.2.
DR   RefSeq; XP_006716723.1; XM_006716660.2.
DR   RefSeq; XP_016869308.1; XM_017013819.1.
DR   RefSeq; XP_016869309.1; XM_017013820.1.
DR   UniGene; Hs.6459; -.
DR   UniGene; Hs.731710; -.
DR   ProteinModelPortal; Q9HAB3; -.
DR   BioGrid; 122725; 4.
DR   IntAct; Q9HAB3; 1.
DR   STRING; 9606.ENSP00000333638; -.
DR   DrugBank; DB01440; Gamma Hydroxybutyric Acid.
DR   TCDB; 2.A.125.1.3; the eukaryotic riboflavin transporter (e-rft) family.
DR   iPTMnet; Q9HAB3; -.
DR   PhosphoSitePlus; Q9HAB3; -.
DR   BioMuta; SLC52A2; -.
DR   DMDM; 74734171; -.
DR   EPD; Q9HAB3; -.
DR   PaxDb; Q9HAB3; -.
DR   PeptideAtlas; Q9HAB3; -.
DR   PRIDE; Q9HAB3; -.
DR   DNASU; 79581; -.
DR   Ensembl; ENST00000329994; ENSP00000333638; ENSG00000185803.
DR   Ensembl; ENST00000402965; ENSP00000385961; ENSG00000185803.
DR   Ensembl; ENST00000527078; ENSP00000434728; ENSG00000185803.
DR   Ensembl; ENST00000530047; ENSP00000435820; ENSG00000185803.
DR   Ensembl; ENST00000532887; ENSP00000436768; ENSG00000185803.
DR   GeneID; 79581; -.
DR   KEGG; hsa:79581; -.
DR   UCSC; uc003zcc.4; human.
DR   CTD; 79581; -.
DR   DisGeNET; 79581; -.
DR   GeneCards; SLC52A2; -.
DR   HGNC; HGNC:30224; SLC52A2.
DR   HPA; HPA063036; -.
DR   MalaCards; SLC52A2; -.
DR   MIM; 607882; gene.
DR   MIM; 614707; phenotype.
DR   neXtProt; NX_Q9HAB3; -.
DR   OpenTargets; ENSG00000185803; -.
DR   Orphanet; 97229; Riboflavin transporter deficiency.
DR   PharmGKB; PA134982935; -.
DR   eggNOG; KOG4255; Eukaryota.
DR   eggNOG; ENOG410YE1U; LUCA.
DR   GeneTree; ENSGT00390000003774; -.
DR   HOGENOM; HOG000247012; -.
DR   HOVERGEN; HBG051170; -.
DR   InParanoid; Q9HAB3; -.
DR   OMA; CADPCDS; -.
DR   OrthoDB; EOG091G0BZA; -.
DR   PhylomeDB; Q9HAB3; -.
DR   TreeFam; TF314820; -.
DR   Reactome; R-HSA-196843; Vitamin B2 (riboflavin) metabolism.
DR   GenomeRNAi; 79581; -.
DR   PRO; PR:Q9HAB3; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000185803; -.
DR   CleanEx; HS_GPR172A; -.
DR   ExpressionAtlas; Q9HAB3; baseline and differential.
DR   Genevisible; Q9HAB3; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032217; F:riboflavin transporter activity; IDA:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006771; P:riboflavin metabolic process; TAS:Reactome.
DR   GO; GO:0032218; P:riboflavin transport; IDA:UniProtKB.
DR   InterPro; IPR009357; Riboflavin_transptr.
DR   PANTHER; PTHR12929; PTHR12929; 1.
DR   Pfam; PF06237; DUF1011; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Deafness; Disease mutation;
KW   Host cell receptor for virus entry; Membrane; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    445       Solute carrier family 52, riboflavin
FT                                transporter, member 2.
FT                                /FTId=PRO_0000042631.
FT   TRANSMEM     14     34       Helical. {ECO:0000255}.
FT   TRANSMEM     47     67       Helical. {ECO:0000255}.
FT   TRANSMEM     86    106       Helical. {ECO:0000255}.
FT   TRANSMEM    112    132       Helical. {ECO:0000255}.
FT   TRANSMEM    147    167       Helical. {ECO:0000255}.
FT   TRANSMEM    196    216       Helical. {ECO:0000255}.
FT   TRANSMEM    277    297       Helical. {ECO:0000255}.
FT   TRANSMEM    312    332       Helical. {ECO:0000255}.
FT   TRANSMEM    339    359       Helical. {ECO:0000255}.
FT   TRANSMEM    366    386       Helical. {ECO:0000255}.
FT   TRANSMEM    404    424       Helical. {ECO:0000255}.
FT   COMPBIAS    219    222       Poly-Pro.
FT   VARIANT      31     31       W -> S (in BVVLS2; strong decrease in
FT                                riboflavin transport; no effect on
FT                                localization to plasma membrane; no
FT                                effect on protein abundance;
FT                                dbSNP:rs797045199).
FT                                {ECO:0000269|PubMed:24253200}.
FT                                /FTId=VAR_077433.
FT   VARIANT      52     52       S -> F (in BVVLS2; decreased riboflavin
FT                                transport; dbSNP:rs397514657).
FT                                {ECO:0000269|PubMed:23243084}.
FT                                /FTId=VAR_077434.
FT   VARIANT     123    123       L -> P (in BVVLS2; strongly decreased
FT                                riboflavin transport; dbSNP:rs397514538).
FT                                {ECO:0000269|PubMed:22864630}.
FT                                /FTId=VAR_077435.
FT   VARIANT     141    141       P -> T (in BVVLS2; decreased riboflavin
FT                                transport; no effect on localization to
FT                                plasma membrane; dbSNP:rs377740960).
FT                                {ECO:0000269|PubMed:27702554}.
FT                                /FTId=VAR_077436.
FT   VARIANT     284    284       A -> D (in BVVLS2; loss of riboflavin
FT                                transport; loss of localization to plasma
FT                                membrane; no effect on protein abundance;
FT                                dbSNP:rs398123067).
FT                                {ECO:0000269|PubMed:24253200}.
FT                                /FTId=VAR_077437.
FT   VARIANT     305    305       Y -> C (in BVVLS2; decreased riboflavin
FT                                transport; decreased localization to
FT                                plasma membrane; no effect on protein
FT                                abundance; dbSNP:rs398123068).
FT                                {ECO:0000269|PubMed:24253200}.
FT                                /FTId=VAR_077438.
FT   VARIANT     306    306       G -> R (in BVVLS2; decreased riboflavin
FT                                transport; decreased localization to
FT                                plasma membrane; no effect on protein
FT                                abundance; dbSNP:rs398124641).
FT                                {ECO:0000269|PubMed:22740598,
FT                                ECO:0000269|PubMed:24253200}.
FT                                /FTId=VAR_068694.
FT   VARIANT     312    312       L -> P (in BVVLS2; decreased riboflavin
FT                                transport; decreased localization to
FT                                plasma membrane; no effect on protein
FT                                abundance; dbSNP:rs754320812).
FT                                {ECO:0000269|PubMed:24253200}.
FT                                /FTId=VAR_077439.
FT   VARIANT     339    339       L -> P (in BVVLS2; loss of riboflavin
FT                                transport; loss of localization to plasma
FT                                membrane; no effect on protein abundance;
FT                                dbSNP:rs148234606).
FT                                {ECO:0000269|PubMed:22864630,
FT                                ECO:0000269|PubMed:24253200}.
FT                                /FTId=VAR_077440.
FT   VARIANT     419    419       G -> S (in BVVLS2; decreased riboflavin
FT                                transport; dbSNP:rs397514658).
FT                                {ECO:0000269|PubMed:23243084}.
FT                                /FTId=VAR_077441.
FT   CONFLICT    341    341       G -> S (in Ref. 1; AAL59882).
FT                                {ECO:0000305}.
SQ   SEQUENCE   445 AA;  45777 MW;  B61421B956E44F84 CRC64;
     MAAPTPARPV LTHLLVALFG MGSWAAVNGI WVELPVVVKE LPEGWSLPSY VSVLVALGNL
     GLLVVTLWRR LAPGKDEQVP IRVVQVLGMV GTALLASLWH HVAPVAGQLH SVAFLALAFV
     LALACCASNV TFLPFLSHLP PRFLRSFFLG QGLSALLPCV LALVQGVGRL ECPPAPINGT
     PGPPLDFLER FPASTFFWAL TALLVASAAA FQGLLLLLPP PPSVPTGELG SGLQVGAPGA
     EEEVEESSPL QEPPSQAAGT TPGPDPKAYQ LLSARSACLL GLLAATNALT NGVLPAVQSF
     SCLPYGRLAY HLAVVLGSAA NPLACFLAMG VLCRSLAGLG GLSLLGVFCG GYLMALAVLS
     PCPPLVGTSA GVVLVVLSWV LCLGVFSYVK VAASSLLHGG GRPALLAAGV AIQVGSLLGA
     VAMFPPTSIY HVFHSRKDCA DPCDS
//
